Effects of TRPV1 on biological behavior of hepatocellular carcinoma and prediction of possible mechanisms

WEI Liling; LIU Meiliang; LI Deyuan; YANG Yu; XIAO Suyang; LI Chanhua; WU Siqian; SONG Anhua; ZENG Xiaoyun

doi:10.16462/j.cnki.zhjbkz.2024.06.012

Volume 28 Issue 6

Jun. 2024

Turn off MathJax

Article Contents

Article Navigation > CHINESE JOURNAL OF DISEASE CONTROL & PREVENTION > 2024 > 28(6): 691-701

WEI Liling, LIU Meiliang, LI Deyuan, YANG Yu, XIAO Suyang, LI Chanhua, WU Siqian, SONG Anhua, ZENG Xiaoyun. Effects of TRPV1 on biological behavior of hepatocellular carcinoma and prediction of possible mechanisms[J]. CHINESE JOURNAL OF DISEASE CONTROL & PREVENTION, 2024, 28(6): 691-701. doi: 10.16462/j.cnki.zhjbkz.2024.06.012

Citation:

WEI Liling, LIU Meiliang, LI Deyuan, YANG Yu, XIAO Suyang, LI Chanhua, WU Siqian, SONG Anhua, ZENG Xiaoyun. Effects of TRPV1 on biological behavior of hepatocellular carcinoma and prediction of possible mechanisms[J]. CHINESE JOURNAL OF DISEASE CONTROL & PREVENTION, 2024, 28(6): 691-701. doi: 10.16462/j.cnki.zhjbkz.2024.06.012

Citation:

WEI Liling, LIU Meiliang, LI Deyuan, YANG Yu, XIAO Suyang, LI Chanhua, WU Siqian, SONG Anhua, ZENG Xiaoyun. Effects of TRPV1 on biological behavior of hepatocellular carcinoma and prediction of possible mechanisms[J]. CHINESE JOURNAL OF DISEASE CONTROL & PREVENTION, 2024, 28(6): 691-701. doi: 10.16462/j.cnki.zhjbkz.2024.06.012

PDF( 22155 KB)

Effects of TRPV1 on biological behavior of hepatocellular carcinoma and prediction of possible mechanisms

doi: 10.16462/j.cnki.zhjbkz.2024.06.012

1.
School of Public Health, Guangxi Medical University, Nanning 530021, China
2.
Teaching and Research Section of Pediatric and Maternal and Child Health, School of Public Health, Guangxi Medical University, Nanning 530021, China
3.
Teaching and Research Section of Epidemiology and Health Statistics, School of Public Health, Guangxi Medical University, Nanning 530021, China

Funds:

Guangxi Natural Science Foundation Key Program 2020GXNSFDA238002

More Information

Corresponding author: ZENG Xiaoyun, E-mail: zengxiaoyun@gxmu.edu.cn
Received Date: 2024-02-26
Rev Recd Date: 2024-05-17

Available Online: 2024-07-13

Publish Date: 2024-06-10

Abstract

Abstract

Objective To clarify the expression of transient receptor potential vanilloid subfamily 1 (TRPV1) in hepatocellular carcinoma (HCC) and its relationship with prognosis, and to explore its effect on the biological behavior of HCC cells. Methods The cancer genome atlas (TCGA), genotype-tissue expression (GTEx) and gene expression ominbus (GEO) databases were utilized to verify the expression of TRPV1 in HCC and its relationship with prognosis. The effects of TRPV1 on the proliferation, migration, invasion, and cell cycle of HCC cells were detected by CCK-8 assay, scratch assay, Transwell assay, and flow cytometry. The expression of cyclin-dependent kinase 4 (CDK4) and cyclin-dependent kinase 6 (CDK6) was detected by Western blot, and the tumor proliferation ability was detected by subcutaneous tumor formation assay in nude mice. Finally, the TRPV1 co-expression network was constructed and analyzed for functional enrichment. Results The expression level of TRPV1 in HCC tissues was down-regulated in TCGA, GTEx, and GEO databases (P < 0.001) and was associated with a shorter overall survival time of patients (P=0.032), with an area under the ROC curve of 0.91. Overexpression of TRPV1 suppressed the proliferation, migration, and invasion ability of HCC cells, blocked cell cycle progression, and CDK4 and CDK6 protein expression levels decreased (both P < 0.05), and the opposite was true for knockdown of TRPV1 (both P < 0.05). After stable overexpression of TRPV1, the subcutaneous tumor volume of nude mice was reduced (P=0.015), the mass of nude mice was reduced (P=0.033), and the positive expression level of Ki-67 protein was down-regulated (P=0.010). TRPV1 co-expressed genes were mainly involved in the processes of RNA splicing, cell cycle protein binding, and cell proliferation. Conclusions TRPV1 inhibited the proliferation, migration, and invasion of HCC cells and blocked cell cycle progression, which exerted an oncogenic role in HCC and provided a new direction for the prognostic analysis and treatment of HCC.
- Transient receptor potential vanilloid 1,
- Hepatocellular carcinoma,
- Proliferation,
- Migration,
- Cell cycle

FullText(HTML)

References(24)

References

[1]	陈宏达, 郑荣寿, 王乐, 等. 2019年中国肿瘤流行病学研究进展[J]. 中华疾病控制杂志, 2020, 24(4): 373-379. DOI: 10.16462/j.cnki.zhjbkz.2020.04.001. Chen HD, Zheng RS, Wang L, et al. Progress in cancer epidemiology research in China in 2019[J]. Chin J Dis Control Prev, 2020, 24(4): 373-379. DOI: 10.16462/j.cnki.zhjbkz.2020.04.001.
[2]	Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2021, 71(3): 209-249. DOI: 10.3322/caac.21660.
[3]	Sia D, Villanueva A, Friedman SL, et al. Liver cancer cell of origin, molecular class, and effects on patient prognosis[J]. Gastroenterology, 2017, 152(4): 745-761. DOI: 10.1053/j.gastro.2016.11.048.
[4]	杨帆, 曹毛毛, 李贺, 等. 1990—2019年中国人群肝癌流行病学趋势分析及预测[J]. 中华消化外科杂志, 2022, 21(1): 106-113. DOI: 10.3760/cma.j.cn115610-20211203-00616. Yang F, Cao MM, Li H, et al. Analysis and prediction of the epidemiological trend of liver cancer in the Chinese population from 1990 to 2019[J]. Chin J Dig Surg, 2022, 21(1): 106-113. DOI: 10.3760/cma.j.cn115610-20211203-00616.
[5]	Mao JJ, Pillai GG, Andrade CJ, et al. Integrative oncology: Addressing the global challenges of cancer prevention and treatment[J]. CA Cancer J Clin, 2022, 72(2): 144-164. DOI: 10.3322/caac.21706.
[6]	Caterina MJ, Schumacher MA, Tominaga M, et al. The capsaicin receptor: a heat-activated ion channel in the pain pathway[J]. Nature, 1997, 389(6653): 816-824. DOI: 10.1038/39807.
[7]	Marrone MC, Morabito A, Giustizieri M, et al. TRPV1 channels are critical brain inflammation detectors and neuropathic pain biomarkers in mice[J]. Nat Commun, 2017, 8: 15292. DOI: 10.1038/ncomms15292.
[8]	Liu ML, Liu X, Liu S, et al. Big data-based identification of multi-gene prognostic signatures in liver cancer[J]. Front Oncol, 2020, 10: 847. DOI: 10.3389/fonc.2020.00847.
[9]	Tu S, Zhang H, Qu XJ. Screening of key methylation-driven genes CDO1 in breast cancer based on WGCNA[J]. Cancer Biomark, 2022, 34(4): 571-582. DOI: 10.3233/cbm-210485.
[10]	Jia F, Zhang BC, Yu WJ, et al. Exploring the cuproptosis-related molecular clusters in the peripheral blood of patients with amyotrophic lateral sclerosis[J]. Compu Biol Med, 2024, 168: 107776. DOI: 10.1016/j.compbiomed.2023.107776.
[11]	Tian Z, He WX, Tang JN, et al. Identification of important modules and biomarkers in breast cancer based on WGCNA[J]. OncoTargets Ther, 2020, 13: 6805-6817. DOI: 10.2147/ott.S258439.
[12]	Gao MM, Kong W, Huang Z, et al. Identification of key genes related to lung squamous cell carcinoma using bioinformatics analysis[J]. International J Mol Sci, 2020, 21(8): 2294. DOI: 10.3390/ijms21082994.
[13]	Xie CZ, Liu GX, Li M, et al. Targeting TRPV1 on cellular plasticity regulated by Ovol 2 and Zeb 1 in hepatocellular carcinoma[J]. Biomed Pharmacother, 2019, 118: 109270. DOI: 10.1016/j.biopha.2019.109270.
[14]	Makale M. Cellular mechanobiology and cancer metastasis[J]. Birth defects research Part C, Embryo today, 2007, 81(4): 329-343. DOI: 10.1002/bdrc.20110.
[15]	Gao NN, Yang F, Chen SY, et al. The role of TRPV1 ion channels in the suppression of gastric cancer development[J]. J Exp Clin Cancer Res, 2020, 39(1): 206. DOI: 10.1186/s13046-020-01707-7.
[16]	Xu SC, Zhang L, Cheng X, et al. Capsaicin inhibits the metastasis of human papillary thyroid carcinoma BCPAP cells through the modulation of the TRPV1 channel[J]. Food Funct, 2018, 9(1): 344-354. DOI: 10.1039/c7fo01295k.
[17]	Weber LV, Al-Refae K, Wölk G, et al. Expression and functionality of TRPV1 in breast cancer cells[J]. Breast cancer, 2016, 8: 243-252. DOI: 10.2147/bctt.S121610.
[18]	付俊文. TRPV1激活calcineurin-NFAT2-p53信号通路诱导结直肠癌细胞凋亡[D]. 泸州: 西南医科大学, 2019, 8: 68. Fu JW. TRPV1 induces apoptosis of colorectal cancer cells by activating calcineurin-NFAT2-p53 signaling pathway[D]. Luzhou: Southwest Medical University, 2019, 8: 68.
[19]	Kastan MB, Bartek J. Cell-cycle checkpoints and cancer[J]. Nature, 2004, 432(7015): 316-323. DOI: 10.1038/nature03097.
[20]	Zhou Y, Zhang QW. Association of tumor suppressor sparcl1 with clinical staging and prognosis of NSCLC[J]. Ann Clin Lab Sci, 2021, 51(6): 756-765.
[21]	Kashyap A, Tripathi G, Tripathi A, et al. RNA splicing: a dual-edged sword for hepatocellular carcinoma[J]. Med Oncol, 2022, 39(11): 173. DOI: 10.1007/s12032-022-01726-8.
[22]	Rinkenbaugh AL, Baldwin AS. The NF-κB pathway and cancer stem cells[J]. Cells, 2016, 5(2): 16. DOI: 10.3390/cells5020016.
[23]	Jin YX, Zhang YY, Huang AK, et al. Overexpression of SERPINA3 suppresses tumor progression by modulating SPOP/NF-κB in lung cancer[J]. Int J Oncol, 2023, 63(2): 96. DOI: 10.3892/ijo.2023.5544.
[24]	Ren DS, Zhuang XY, Lv YX, et al. FAM84B promotes the proliferation of glioma cells through the cell cycle pathways[J]. World J Surg Oncol, 2022, 20(1): 368. DOI: 10.1186/s12957-022-02831-8.